A comparative analysis of the costs and outcomes of therapy involving the proposed drug and therapy involving its main comparator(s). An umbrella term covering CBA, CEA, CMA and CUA. The analysis involves identification, measurement and valuation of the differences in costs and outcomes caused by substituting therapy involving the proposed drug for therapy involving its main comparator(s).